Pharma's Almanac: Nice Insight's Content Community

Articles
Expert Interviews
Roundtable
Press Releases
Videos
Thought Leaders

Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing

Cambrex

Sort By

Nice Insight is the market research division of That’s Nice LLC, the leading marketing agency serving life sciences.

Explore

About Us
Nice Insight
That's Nice

Reach Out Team

Contact Us
Advertise

My Account

Login/Sign up

Site

Privacy Policy
Terms And Conditions

© 2024 PHARMA’S ALMANAC. All rights reserved.

1 / 1

1 / 1

How can Life Science Technology Providers Support the Pharmaceutical Industry in the Transition Toward More Digitally Connected Operations?

Digitalization

How can Life Science Technology Providers Support the Pharmaceutical Industry in the Transition Toward More Digitally Connected Operations?

Pharma's Almanac

PAO-06-24-RT-02June 24, 2024

What are the Current Investment Trends in the Pharmaceutical Industry, and How are They Influencing the Sector’s Direction?

Investment

What are the Current Investment Trends in the Pharmaceutical Industry, and How are They Influencing the Sector’s Direction?

Pharma's Almanac

PAO-06-24-RT-01June 24, 2024

Cambrex to be Acquired by the Permira Funds for $60.00 per Share in Cash

M&A

Cambrex to be Acquired by the Permira Funds for $60.00 per Share in Cash

Cambrex

PR-M08-19-NI-023-2284August 08, 2019

Cambrex Adds New Lab Space

Capacity Expansion

Cambrex Adds New Lab Space

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-M06-19-NI-009June 17, 2019

Highly Potent API and Sterile Capabilities Key to DCAT Week ‘19 Company Announcements

DCAT '19

Highly Potent API and Sterile Capabilities Key to DCAT Week ‘19 Company Announcements

David Alvaro, Ph.D.

Pharma's Almanac

PAO-M03-19-NI-024March 18, 2019

Cambrex to Acquire Halo Pharma, Adding Drug Development and Finished Dosage Capabilities to Global API Manufacturing Network

API Manufacturing

Cambrex to Acquire Halo Pharma, Adding Drug Development and Finished Dosage Capabilities to Global API Manufacturing Network

Cambrex Corporation

PR-M07-18-NI-082July 25, 2018

Cambrex Expands Process Research and Development Capabilities Across North America

Expanded Capacity

Cambrex Expands Process Research and Development Capabilities Across North America

Cambrex

PR-M02-18-NI-014February 05, 2018

Cambrex & AstraZeneca Hold Ceremony to Mark Long-Term Supply Agreement at Karlskoga, Sweden Facility

Ceremony

Cambrex & AstraZeneca Hold Ceremony to Mark Long-Term Supply Agreement at Karlskoga, Sweden Facility

Cambrex Corporation

PR-M01-18-NI-062January 19, 2018

Cambrex Invests in New Highly Potent API Manufacturing Capacity

API

Cambrex Invests in New Highly Potent API Manufacturing Capacity

Steve Kuehn

Nice Insight

PAO-M08-17-NI-016August 11, 2017